STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
Jun. 17, 2025 |
Jun. 03, 2025 |
May 08, 2025 |
Apr. 25, 2025 |
Mar. 03, 2025 |
Feb. 24, 2025 |
Apr. 25, 2024 |
Mar. 28, 2024 |
Mar. 14, 2024 |
Nov. 17, 2023 |
Nov. 15, 2023 |
Nov. 13, 2023 |
Nov. 09, 2023 |
May 25, 2023 |
Aug. 03, 2022 |
Aug. 01, 2022 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
May 22, 2025 |
Mar. 22, 2025 |
Dec. 23, 2024 |
May 31, 2024 |
Mar. 25, 2024 |
Feb. 14, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,000,000
|
150,000,000
|
|
|
|
150,000,000
|
|
70,000,000
|
|
|
|
|
|
|
|
|
Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000,000
|
30,000,000
|
|
|
|
30,000,000
|
|
30,000,000
|
30,000,000
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 61,132
|
$ 130,220
|
$ 315,314
|
$ 179,628
|
|
|
|
|
|
|
|
|
|
|
|
Issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,261
|
|
|
|
|
|
|
|
|
|
|
|
Private placement offerings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
115,493
|
$ 74,448
|
5,030
|
$ 50,000
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights exercisable period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jan. 23, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right date from which warrants or rights expire |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jul. 27, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price per share |
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 years
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
$ 105,154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 260,602
|
|
$ 5,157,493
|
|
$ (565,387)
|
$ 9,338,791
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,143,192
|
|
5,442,246
|
|
10,143,192
|
5,442,246
|
6,718,176
|
|
|
|
|
|
|
3,650,278
|
|
Proceeds from warrant exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 328,924
|
|
|
|
|
|
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,952,412
|
|
|
|
11,952,412
|
|
9,769,992
|
|
|
|
|
|
|
|
|
Percentage of shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
Exercise price percentage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110.00%
|
|
|
|
|
|
|
|
|
|
|
2021 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,674,911
|
|
|
|
6,674,911
|
|
|
|
|
|
|
|
|
|
|
Common stock reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,909,518
|
1,556,089
|
|
|
|
1,556,089
|
|
2,250,000
|
|
|
|
|
|
|
2,838,668
|
1,956,993
|
Percentage of increase in stock outstanding fully diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2018 Stock Option Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,773,912
|
|
|
|
1,773,912
|
|
|
|
|
|
|
|
|
|
|
Amended And Restated 2020 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,503,589
|
|
|
|
3,503,589
|
|
|
|
|
|
|
|
|
|
|
Common stock reserved for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
Alumni Capital Lp [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights exercisable period |
|
|
|
|
|
|
|
|
|
|
|
|
Nov. 10, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right date from which warrants or rights expire |
|
|
|
|
|
|
|
|
|
|
|
|
Nov. 10, 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
$ 84,251
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
3 years 10 months 13 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
3.93%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant shares vested |
|
|
|
|
|
|
|
|
|
|
|
131,578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 343,735
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.82%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting expense for restricted shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 31,570
|
|
|
|
|
|
|
|
|
|
|
Research and Development Expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting expense for restricted shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 30,751
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consulting expense for restricted shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,500
|
|
|
|
|
|
|
|
|
|
Shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,123
|
12,500
|
|
|
|
|
|
|
|
|
|
Unvested shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
0
|
|
0
|
0
|
|
|
|
|
|
|
|
|
|
Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.25
|
$ 2.41
|
|
|
|
|
|
|
|
|
|
Unrecognized compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,339,230
|
|
|
|
$ 4,339,230
|
|
|
|
|
|
|
|
|
|
|
Unrecognized compensation expense, recognized period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 11 months 8 days
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
793,429
|
666,323
|
2,015,122
|
507,754
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock |
219,283
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from warrant exercise |
$ 328,924
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Director [Member] | 2021 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
33,333
|
86,666
|
|
58,333
|
123,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,040
|
|
|
|
17,083
|
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, price per share |
|
$ 1.50
|
$ 1.50
|
|
$ 1.50
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private placement offerings |
|
$ 700,000
|
$ 1,080,000.00
|
|
$ 1,400,000
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights exercisable period |
|
|
|
|
Mar. 03, 2026
|
Feb. 24, 2031
|
|
|
Sep. 14, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right date from which warrants or rights expire |
|
|
|
|
Mar. 03, 2031
|
|
|
|
Sep. 14, 2029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price per share |
|
|
|
|
|
|
|
|
$ 1.30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,793,921
|
|
|
|
|
|
|
$ 5,089,063
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,744,321
|
$ 769,671
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] | Amendment Of Warrant Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 437,031
|
|
|
|
|
Private Placement [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
$ 677,919
|
|
$ 2,049,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
5 years 6 months
|
|
5 years 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
4.70%
|
|
4.20%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
95.00%
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] | Black Sholes Method [Member] | Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
$ 346,606
|
|
$ 230,685
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
5 years 6 months
|
|
5 years 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
4.70%
|
|
4.20%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
95.00%
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
463,332
|
719,999
|
|
952,633
|
1,810,000
|
|
|
2,496,318
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement [Member] | Investor Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
463,332
|
719,999
|
|
952,633
|
1,810,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, price per share |
|
$ 1.71
|
$ 2.05
|
|
$ 1.85
|
$ 1.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights exercisable period |
|
Dec. 03, 2025
|
May 08, 2026
|
|
|
Feb. 24, 2026
|
Oct. 25, 2024
|
Sep. 28, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right date from which warrants or rights expire |
|
Jun. 03, 2030
|
May 08, 2031
|
|
Mar. 03, 2031
|
Feb. 24, 2031
|
Oct. 25, 2029
|
Sep. 28, 2029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase aggregate of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
437,031
|
|
|
|
|
Private Placement Offering [Member] | Amendment Of Warrant Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,011,562
|
|
|
|
|
Private Placement Offering [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
$ 1,190,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
5 years 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
4.20%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
216,131
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] | Black Sholes Method [Member] | Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
$ 43,358
|
$ 133,131
|
|
$ 80,894
|
$ 176,680
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
5 years
|
6 years
|
|
6 years
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
4.04%
|
4.09%
|
|
3.97%
|
4.23%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
95.00%
|
95.00%
|
|
95.00%
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] | Common Stock [Member] | Director [Member] | 2021 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
|
|
167,157
|
|
|
|
|
452,731
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] | Common Stock [Member] | Non Affiliated Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
429,999
|
633,333
|
|
894,300
|
|
326,939
|
|
2,043,587
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] | Common Stock [Member] | Affiliated And Non Affiliated Investors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
|
|
|
|
1,686,667
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] | Investor Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
463,332
|
719,999
|
|
|
1,810,000
|
494,096
|
578,643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, price per share |
|
$ 1.50
|
$ 1.50
|
|
|
$ 1.87
|
$ 2.26
|
$ 2.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering [Member] | Outside Investors Warrants [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
$ 559,324
|
$ 972,890
|
|
$ 1,240,185
|
$ 2,416,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
5 years
|
6 years
|
|
6 years
|
6 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
4.04%
|
4.09%
|
|
3.97%
|
4.23%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
95.00%
|
95.00%
|
|
95.00%
|
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IPO [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 39,596
|
|
|
|
39,596
|
|
$ 71,672
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,076
|
|
$ 96,732
|
|
32,076
|
169,398
|
|
|
|
|
|
|
|
|
|
Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights exercisable period |
|
|
|
|
|
|
|
|
|
|
Nov. 15, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right date from which warrants or rights expire |
|
|
|
|
|
|
|
|
|
|
Nov. 15, 2028
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase aggregate of common stock |
|
|
|
|
|
|
|
|
|
|
169,697
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant exercise price per share |
|
|
|
|
|
|
|
|
|
$ 1.86
|
$ 2.06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
$ 1,903,915
|
$ 123,811
|
|
|
|
|
|
180,233
|
|
|
|
180,233
|
|
$ 230,038
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
5 years 4 months 17 days
|
4 years 10 months 17 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk free interest rate |
|
|
|
|
|
|
|
|
|
3.85%
|
3.84%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
|
|
|
|
|
|
|
|
|
90.00%
|
90.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,546
|
|
181,705
|
|
15,741
|
338,664
|
|
|
|
|
|
|
|
|
|
Registered Direct Offering [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
458,726
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
$ 2,815,970
|
|
|
|
|
|
|
1,756,035
|
|
|
|
1,756,035
|
|
$ 2,189,478
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
246,105
|
|
805,104
|
|
433,443
|
3,112,936
|
|
|
|
|
|
|
|
|
|
Issuance of common shares upon cashless exercise of warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
909,091
|
|
|
|
|
|
|
|
|
Increase in equity on exercise of warrant liability |
|
|
|
|
|
|
|
|
|
$ 2,815,970
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private Placement Offering One [Member] | Amendment Of Warrant Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,354
|
|
|
|
149,354
|
|
$ 199,417
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,564
|
|
$ 91,752
|
|
$ 50,063
|
91,752
|
|
|
|
|
|
|
|
|
|
Remaining warrant liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141,612
|
|
|
|
141,612
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity increase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 769,671
|
|
|
|
|
|
|
|
|
|
Private Placement Offering One [Member] | Black Sholes Method [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 973,980
|
|
|
|
|
|
|
|
|
|
|
|
H C Wainwright And Co LLC [Member] | At The Market Offering Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
Number of common stock sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
793,429
|
|
2,015,122
|
|
|
|
|
|
|
|
|
|
|
|
|
Sale of common stock, price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.87
|
|
$ 3.53
|
|
$ 1.87
|
$ 3.53
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,480,894
|
|
$ 7,116,978
|
|
|
|
|
|
|
|
|
|
|
|
|
Commissions paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,427
|
|
213,509
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,705
|
|
101,805
|
|
|
|
|
|
|
|
|
|
|
|
|
Net proceeds from common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,419,762
|
|
6,801,664
|
|
|
|
|
|
|
|
|
|
|
|
|
Laidlaw And Company Ltd [Member] | Alumni Capital Lp [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants and rights exercisable period |
|
|
|
|
|
|
|
|
|
|
|
|
May 22, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
$ 375,705
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
Fair value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 175,803
|
|
|
$ 291,454
|
|
|
|
|
|
|
|
|
|
Warrant fee paid in cash |
|
|
|
|
|
|
|
|
|
|
|
|
$ 13,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common shares upon cashless exercise of warrants, shares |
|
|
|
|
|
|
|
|
|
|
|
54,976
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,000,000
|
|
|
|
|
|
|
|
Minimum [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
5 years
|
|
|
|
|
|
|
|
|
|
Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000,000
|
|
|
|
|
|
|
|
Warrants to purchase aggregate of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | 2021 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of authorized amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.00%
|
|
|
|
|
|
|
|
|
Maximum [Member] | Alumni Capital Lp [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase aggregate of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
239,234
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value assumptions, contractual term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years 29 days
|
6 years 3 months
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | Over-Allotment Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of warrant or right additional purchase aggregate of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | Registered Direct Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase aggregate of common stock |
|
|
|
|
|
|
|
|
|
2,424,243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum [Member] | H C Wainwright And Co LLC [Member] | At The Market Offering Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate offering price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11,200,000
|
$ 30,000,000
|
|
$ 4,950,000
|
$ 1,445,000
|
|
|